ATE459002T1 - Verfahren zur einschätzung des risikos maligner tumorrezidive - Google Patents

Verfahren zur einschätzung des risikos maligner tumorrezidive

Info

Publication number
ATE459002T1
ATE459002T1 AT07004033T AT07004033T ATE459002T1 AT E459002 T1 ATE459002 T1 AT E459002T1 AT 07004033 T AT07004033 T AT 07004033T AT 07004033 T AT07004033 T AT 07004033T AT E459002 T1 ATE459002 T1 AT E459002T1
Authority
AT
Austria
Prior art keywords
comparing
parameter
malignant tumor
judging
contained
Prior art date
Application number
AT07004033T
Other languages
English (en)
Inventor
Satoshi Tanaka
Masaki Shibayama
Hideki Ishihara
Tomoko Matsushima
Aya Katayama
Yuko Kawasaki
Original Assignee
Sysmex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sysmex Corp filed Critical Sysmex Corp
Application granted granted Critical
Publication of ATE459002T1 publication Critical patent/ATE459002T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4739—Cyclin; Prad 1
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Data Mining & Analysis (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Public Health (AREA)
  • Evolutionary Biology (AREA)
  • Evolutionary Computation (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Databases & Information Systems (AREA)
  • Software Systems (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
AT07004033T 2006-02-28 2007-02-27 Verfahren zur einschätzung des risikos maligner tumorrezidive ATE459002T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006053945 2006-02-28
JP2006345880A JP2007259846A (ja) 2006-02-28 2006-12-22 悪性腫瘍の性質の判定方法

Publications (1)

Publication Number Publication Date
ATE459002T1 true ATE459002T1 (de) 2010-03-15

Family

ID=38121532

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07004033T ATE459002T1 (de) 2006-02-28 2007-02-27 Verfahren zur einschätzung des risikos maligner tumorrezidive

Country Status (5)

Country Link
US (1) US8041514B2 (de)
EP (1) EP1826568B1 (de)
JP (1) JP2007259846A (de)
AT (1) ATE459002T1 (de)
DE (1) DE602007004889D1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5111902B2 (ja) * 2007-03-14 2013-01-09 シスメックス株式会社 癌の診断支援装置
JP5351427B2 (ja) * 2008-03-28 2013-11-27 シスメックス株式会社 癌の再発リスクを判定する方法及び癌の再発リスク診断の支援方法
JP2010057486A (ja) * 2008-09-02 2010-03-18 Sysmex Corp 化学療法に対するがん患者の応答の予測方法
WO2020111379A1 (en) * 2018-11-26 2020-06-04 National Cancer Center A method for screening a therapeutic agent for cancer using binding inhibitor of cyclin-dependent kinase 1 (cdk1)-cyclin b1 and retinoic acid receptor responder 1 (rarres1) gene knockout animal model
KR102138229B1 (ko) * 2018-11-26 2020-07-28 국립암센터 CDK1-Cyclin B1의 결합 억제제를 이용한 암 치료물질의 스크리닝 방법
WO2021150945A1 (en) * 2020-01-23 2021-07-29 Icahn School Of Medicine At Mount Sinai Methods of diagnosing and treating cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1699799A (en) * 1997-11-20 1999-06-15 Beth Israel Deaconess Medical Center Neonatal illness severity/mortality computerized determination syste m & method
JP4317188B2 (ja) 2003-02-26 2009-08-19 シスメックス株式会社 細胞の検査方法
US20050136177A1 (en) * 2003-08-25 2005-06-23 Anthony Hesse Method for coloring landscaping materials using foamable dry colorant
US7957910B2 (en) 2005-01-31 2011-06-07 Sysmex Corporation Method for predicting effectiveness of chemotherapy
EP1750131B1 (de) 2005-08-01 2008-07-09 Sysmex Corporation Verfahren zur Beurteilung der Beschaffenheit maligner Tumore
JP4766969B2 (ja) 2005-09-14 2011-09-07 シスメックス株式会社 組織性質判定装置

Also Published As

Publication number Publication date
US20070202555A1 (en) 2007-08-30
JP2007259846A (ja) 2007-10-11
EP1826568A1 (de) 2007-08-29
EP1826568B1 (de) 2010-02-24
DE602007004889D1 (de) 2010-04-08
US8041514B2 (en) 2011-10-18

Similar Documents

Publication Publication Date Title
ATE459002T1 (de) Verfahren zur einschätzung des risikos maligner tumorrezidive
DE602005024964D1 (de) Verfahren zur beurteilung der malignität einer säuger-krebszelle
NZ616755A (en) Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
ATE426806T1 (de) Verfahren zur prognose der wirksamkeit von chemotherapie
TW200943119A (en) Processing of biological growth media based on measured manufacturing characteristics
WO2004030511A3 (en) Prostate cancer biomarkers
WO2005118659A3 (en) Methods of view selection for radioactive emission measurements
DE602005013998D1 (de) Verfahren und reagenzien zur erkennung von melanomen
WO2009064933A3 (en) Detection of circulating tumor cells in peripheral blood with an automated scanning fluorescence microscope
WO2009054939A8 (en) Cancer classification and methods of use
ATE535805T1 (de) Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen
WO2006138275A3 (en) Compositions and methods for treating and diagnosing cancer
WO2006063711A3 (en) Method for the determining the water saturation of an underground formation
WO2008121132A3 (en) Gene expression profiling for identification, monitoring, and treatment of prostate cancer
GB201017876D0 (en) Database systems and methods
WO2007076523A3 (en) Markers and methods for assessing and treating psoriasis and related disorders
DK1842920T3 (da) Celler der co-udtrykker K-vitaminreduktase og K-vitaminafhængigt protein, samt anvendelse deraf til at forbedre produktiviteten af det K-vitaminafhængige protein
ATE531821T1 (de) Verfahren und vorrichtung zur beurteilung des vorliegens oder nichtvorliegens einer krebszelle
DE50311312D1 (de) Verfahren zum untersuchen von körperflüssikeiten auf krebszellen sowie entsprechende analysekits
WO2006089062A3 (en) Detection of biomarkers for neuropsychiatric disorders
TW200602084A (en) Method for reducing ultraviolet light induced apoptosis
DE602006001701D1 (de) Verfahren zur Beurteilung der Beschaffenheit maligner Tumore
WO2009085852A3 (en) Method and apparatus for improving performance of erasure sequence detection
WO2006048266A3 (en) Gene expression profiling of leukemias with mll gene rearrangements
WO2010025005A3 (en) Bulk image modeling for optical proximity correction

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties